POLYPHOR – INNOVATION IN DRUG DISCOVERY
Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs.
These macrocycles represent a new drug class complementary to the classical small molecules and large biopharmaceuticals.
Our proprietary and unique technologies are broadly applicable to a wide array of biological targets and disease areas and provide innovative treatment options.
We leverage our technologies to develop our own product portfolio and to pursue licensing and collaboration opportunities.
November 12, 2014 - Polyphor’s lead antibiotic POL7080 receives Qualified Infectious...
November 4, 2013 - Polyphor and Roche join efforts to combat multi-drug resistant...
July 31, 2013 - Polyphor achieves first milestone in MacroFinder® collaboration...
Hegenheimermattweg 125, CH-4123 Allschwil, Switzerland
Tel. +41 61 567 16 00, Fax +41 61 567 16 01, email@example.com
Last modified: 12.11.2014